U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07378176) titled 'Prognosis of Primary Aldosteronism: A Prospective Cohort Study' on Jan. 22.
Brief Summary: Primary aldosteronism (PA) is the most common cause of secondary hypertension, and patients with PA have a significantly higher risk of developing cardiovascular and renal complications compared with those with essential hypertension. However, PA remains substantially underdiagnosed and undertreated in clinical practice, and relevant research data on the short-term and long-term prognosis of PA patients in the Chinese population are particularly scarce. This is a multicenter, prospective cohort study designed to systematically collect real-wor...